Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Other Non-Current Assets (2016 - 2025)

National Healthcare (NHC) has disclosed Other Non-Current Assets for 16 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 0.57% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2025, up 0.57%, and an annual FY2025 reading of $1.2 million, up 0.57% over the prior year.
  • Other Non-Current Assets was $1.2 million for Q4 2025 at National Healthcare, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $415.0 million in Q4 2022 and bottomed at $1.1 million in Q3 2023.
  • Average Other Non-Current Assets over 5 years is $45.8 million, with a median of $3.2 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets plummeted 99.58% in 2021, then skyrocketed 9123.96% in 2022.
  • Year by year, Other Non-Current Assets stood at $4.5 million in 2021, then surged by 9123.96% to $415.0 million in 2022, then tumbled by 96.44% to $14.8 million in 2023, then plummeted by 91.66% to $1.2 million in 2024, then rose by 0.57% to $1.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for NHC at $1.2 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.